Stay updated on Cabozantinib for NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for NSCLC Brain Metastases Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study status is updated to Terminated due to slow patient accrual. Results have been added with Results First Posted on 2020-09-16.
    Difference
    0.4%
    Check dated 2025-11-03T12:53:07.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    30 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    2%
    Check dated 2025-10-05T17:37:19.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Upgrade from v3.0.2 to v3.1.0: version metadata updated; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T10:54:23.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:43:36.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T21:17:14.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details while removing specific geographic references and some related medical topics. Notably, the topic of Lung Cancer has been removed from the MedlinePlus related topics.
    Difference
    2%
    Check dated 2025-08-30T15:45:18.000Z thumbnail image

Stay in the know with updates to Cabozantinib for NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.